Talazoparib nanoparticles for overcoming multidrug resistance in triple-negative breast cancer

dc.date.accessioned	2020-10-21T06:46:24Z
dc.date.available	2020-10-21T06:46:24Z
dc.date.issued	2020
dc.date.issued	2020/02/05
dc.identifier.citation	Cecener G, Egeli U, Tunca B..J Cell Physiol. 2020 Sep;235(9):6230-6245. doi: 10.1002/jcp.29552. Epub 2020 Feb 3.
dc.identifier.uri	http://doi.org/10.1002/jcp.29552
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71855
dc.description	PMID = 32017076
dc.relation.isversionof	10.1002/jcp.29552
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Talazoparib nanoparticles for overcoming multidrug resistance in triple-negative breast cancer
dc.type	article
dc.relation.journal	J Cell Physiol
dc.identifier.doi	10.1002/jcp.29552
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Cecener G
dc.contributor.author	Egeli U
dc.contributor.author	Tunca B.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi